Evidence map›Paper›PMID 31249452›Full record

SynthesisWorld journal of gastroenterology2019

Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.

Pamela A Norton, Anand S Mehta

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Golgi Drivers of Cancer.Sub-cellular biochemistry · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Core fucosylation and its roles in gastrointestinal glycoimmunology.World journal of gastrointestinal oncology · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. GANAB andInternational journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Pamela A NortonDepartment of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, United States. pan29@drexel.edu.
Anand S MehtaDepartment of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC 29425, United States.
Drexel University · USMedical University of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChanges in N-linked glycosylation have been observed in the circulation of individuals with hepatocellular carcinoma. In particular, an elevation in the level of core fucosylation has been observed. However, the mechanisms through which core fucose is increased are not well understood. We hypothesized that a review of the literature and related bioinformatic review regarding six genes known to be involved in the attachment of core fucosylation, the synthesis of the fucosylation substrate guanosine diphosphate (GDP)-fucose, or the transport of the substrate into the Golgi might offer mechanistic insight into the regulation of core fucose levels.

aimTo survey the literature to capture the involvement of genes regulating core N-linked fucosylation in hepatocellular carcinoma.

methodsThe PubMed biomedical literature database was searched for the association of hepatocellular carcinoma and each of the core fucose-related genes and their protein products. We also queried The Cancer Genome Atlas Liver hepatocellular carcinoma (LIHC) dataset for genetic, epigenetic and gene expression changes for the set of six genes using the tools at cBioportal.

resultsA total of 27 citations involving one or more of the core fucosylation-related genes (FPGT, FUK, FUT8, GMDS, SLC35C1, TSTA3) and hepatocellular carcinoma were identified. The same set of gene symbols was used to query the 371 patients with liver cancer in the LIHC dataset to identify the frequency of mRNA over or under expression, as well as non-synonymous mutations, copy number variation and methylation level. Although all six genes trended to more samples displaying over expression relative to under-expression, it was noted that a number of tumor samples had undergone amplification of the genes of the

conclusionAmplification of genes involved in the

Indexed as

Gene Expression Regulation, NeoplasticCarbohydrate EpimerasesCarcinoma, HepatocellularDNA Copy Number VariationsDNA MethylationGlycoproteinsGlycosylationGuanosine Diphosphate FucoseHumansHydro-LyasesKetone OxidoreductasesLiver NeoplasmsMetabolic Networks and PathwaysMutationCarbohydrate EpimerasesGlycoproteinsGMDS protein, humanGuanosine Diphosphate FucoseHydro-LyasesKetone OxidoreductasesTSTA3 protein, humanFucoseGuanosine diphosphate fucoseHepatocellular carcinomaLiver cancerN-linked glycosylation

Identifiers

PMID31249452
PMCPMC6589740
OpenAlexW2949204189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.